1) Antidepressants in Parkinson disease and 2) Topic of the month: Obesity and the neurology patient. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matt Barrett interviews Dr. Irene Richard about her paper on antidepressants in Parkinson disease. Dr. Chafic Karam is reading our e-Pearl of the week about migraine without aura. In the next part of the podcast Dr. Brett Kissela interviews Dr. Mitch Elkind about stroke and obesity. Next week, Dr. Burns will interview Dr. Lisa Davis about her recent paper published in the March Neurology Clinical Practice Journal. The participants had nothing to disclose except Drs. Richard, Karam, Kissela, and Elkind.Dr. Richard serves on a scientific advisory board for the Michael J. Fox Foundation; has received a speaker honorarium from Teva Pharmaceutical Industries Ltd.; and receives/has received research support from Neurologix, Inc., Eli Lilly and Company, the NIH/NINDS, Cornell University, and the Michael J. Fox Foundation.Dr. Karam serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory boards for Northstar Neuroscience and Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from NexStim and the NIH, and provides medico-legal reviews.Dr. Elkind serves as the Associate Editor of the Neurology® Resident and Fellow Section, serves on an event adjudication committee for Jarvik Heart, receives research support from the NIH, diaDexus, Inc. Sanofi-Aventis, serves on the New York City and Founders Affiliate Boards for the American Heart Association, and has served as a consultant in stroke litigation-legal proceedings.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related